THC Farmaceuticals Inc
OTC:CBDG
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
T
|
THC Farmaceuticals Inc
OTC:CBDG
|
322.7k USD |
Loading...
|
|
| US |
|
Cintas Corp
NASDAQ:CTAS
|
78.1B USD |
Loading...
|
|
| US |
|
Copart Inc
NASDAQ:CPRT
|
39B USD |
Loading...
|
|
| AU |
|
Brambles Ltd
ASX:BXB
|
31.5B AUD |
Loading...
|
|
| CA |
|
Ritchie Bros Auctioneers Inc
TSX:RBA
|
29.7B CAD |
Loading...
|
|
| US |
|
RB Global Inc
F:J1F
|
18B EUR |
Loading...
|
|
| FR |
|
Spie SA
PAR:SPIE
|
8.2B EUR |
Loading...
|
|
| US |
|
Aurora Innovation Inc
NASDAQ:AUR
|
8.5B USD |
Loading...
|
|
| FR |
|
Elis SA
PAR:ELIS
|
6.2B EUR |
Loading...
|
|
| DK |
|
Iss A/S
CSE:ISS
|
43.5B DKK |
Loading...
|
|
| US |
I
|
IAA Inc
F:3NI
|
4.9B EUR |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
THC Farmaceuticals Inc
Glance View
THC Farmaceuticals, Inc. engages in the research and development of cannabis pharmaceutical products. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2012-08-22. The firm through its subsidiary CBDual Biotechnology Corp., a pharmaceutical start-up company focuses on developing products based on cannabidiol (CBD) and/or Tetrahydrocannabinol (THC). The firm is engaged cannabis formulations, edibles, and delivery systems of cannabis. The company manufactures and markets cannabis extract products made from cannabis. The firm's facility is located in Southern California. The company provides access for patients to participate in clinical trials of new medical cannabis medications, therapies, and products. The firm is focusing on the research of psilocybin for the purpose of conducting clinical trials involving the combination of genetic testing and micro-dosing of psilocybin formulations.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 2 years, THC Farmaceuticals Inc’s Gross Margin has decreased from 100% to 100%. During this period, it reached a low of 100% on Dec 1, 2018 and a high of 100% on Oct 30, 2020.
